Abstract
The models available in the literature for the in silico prediction of ADME (absorption, distribution, metabolism, excretion) properties, as well as the data sets used to derive them, are reviewed. Special emphasis is given to describe the latest and most complete models, with the largest and most diverse data sets. Models for human intestinal absorption, oral bioavailability, plasma protein binding, blood-brain barrier permeation, Pglycoprotein substrates and inhibitors, and metabolism are reviewed and discussed. An attempt is made to describe the general picture emerging from each set of models when possible, as well as the issues remaining to address in the different areas for future work. These models are an example of the utility of models and computer simulations for the prediction of pharmacokinetics.
Keywords: in silico adme prediction, qsar, human intestinal absorption, bioavailability, plasma protein binding, bloodbrain barrier permeation, p-glycoprotein, metabolism
Current Computer-Aided Drug Design
Title: In Silico ADME Prediction: Data Sets and Models
Volume: 1 Issue: 4
Author(s): Gonzalo Colmenarejo
Affiliation:
Keywords: in silico adme prediction, qsar, human intestinal absorption, bioavailability, plasma protein binding, bloodbrain barrier permeation, p-glycoprotein, metabolism
Abstract: The models available in the literature for the in silico prediction of ADME (absorption, distribution, metabolism, excretion) properties, as well as the data sets used to derive them, are reviewed. Special emphasis is given to describe the latest and most complete models, with the largest and most diverse data sets. Models for human intestinal absorption, oral bioavailability, plasma protein binding, blood-brain barrier permeation, Pglycoprotein substrates and inhibitors, and metabolism are reviewed and discussed. An attempt is made to describe the general picture emerging from each set of models when possible, as well as the issues remaining to address in the different areas for future work. These models are an example of the utility of models and computer simulations for the prediction of pharmacokinetics.
Export Options
About this article
Cite this article as:
Colmenarejo Gonzalo, In Silico ADME Prediction: Data Sets and Models, Current Computer-Aided Drug Design 2005; 1 (4) . https://dx.doi.org/10.2174/157340905774330318
DOI https://dx.doi.org/10.2174/157340905774330318 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Programs to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicrobial Acquisition and Coordinating Facility
Infectious Disorders - Drug Targets Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Multi-Component Reactions Using Indium(III) Salts
Current Organic Chemistry Implication of CD154/CD40 Interaction in Healthy and Autoimmune Responses
Current Immunology Reviews (Discontinued) Recent Patents of Gene Sequences Relative to the Phosphatidylinositol 3-kinase / Akt Pathway and their Relevance to Drug Discovery
Recent Patents on DNA & Gene Sequences New Issues for Copper-64: from Precursor to Innovative Pet Tracers in Clinical Oncology
Current Radiopharmaceuticals Preparation and Characterization of Chitosan Monomer/Organic Rectorite Nanocomposite
Current Nanoscience In Vitro and In Vivo Evaluation of Guar Gum-Based Matrix Tablets of Rofecoxib for Colonic Drug Delivery
Current Drug Delivery Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Current Cancer Drug Targets Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies
Anti-Cancer Agents in Medicinal Chemistry Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Ultrasound Contrast Imaging in Cancer –Technical Aspects and Prospects
Current Molecular Imaging (Discontinued) Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status
Current Respiratory Medicine Reviews In Silico Modeling of P450 Substrates, Inhibitors, Activators, and Inducers
Combinatorial Chemistry & High Throughput Screening